Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas
NCT04520529
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Cutaneous Lymphoma
Interventions
OTHER:
Biologic Samples
Sponsor
Assistance Publique - Hôpitaux de Paris